be noted that the evidence and consensus used to inform this guideline were drawn primarily from orthopedic literature. As in the prior version, this guideline does not address indications for THA or TKA, medical decisions unrelated to antirheumatic drug therapy, the choice of the implant, the surgical approach, or the perioperative evaluation and management of concurrent disease, such as that affecting the cervical spine of patients with RA. Although routine perioperative care and preoperative optimization for patients with RA, SpA, JIA, or SLE include assessing risk of venous thromboembolism and major acute coronary events https://www. rheumatology.org/Practice-Quality/Clinical-Support/Clinical-Practi ce-Guidelines 1 2 http://onlinelibrary.wiley.com/doi/ 1 2 The Voting Panel included 2 patients who have undergone arthroplasty surgery and who participated in the 2017 guideline's Patient Panel, one of whom participated in the previous Voting Panel. The panel reviewed evidence